TABLE 1.
Determination of RFX MICs against clinical isolates of MDR bacterial speciesa
| Bacterial species | No. of strains tested | MIC50 (mg/liter) | MIC90 (mg/liter) |
|---|---|---|---|
| Pseudomonas aeruginosa | 26 | 8 | 16 |
| Staphylococcus aureus | 22 | 2 | 16 |
| Acinetobacter baumannii | 9 | <0.5 | <0.5 |
| Burkholderia cepacia | 4 | 16 | 32 |
| Stenotrophomonas maltophilia | 1 | 16 | 16 |
a
Sources of clinical isolates are listed in Table S2 in the supplemental material. MIC50 and MIC90 are the concentrations of RFX required for the growth inhibition of 50% and 90% of strains, respectively.